T
Tailong Investment
Hangzhou
Overview
Tailong Investment is a venture capital firm founded in 2021 that focuses on investments in biopharmaceuticals, innovative medical devices, and CXO core services.
Year Founded
2021
Portfolio Companies
6
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Leman Biotech | Mar 2026 | Series A Extension | Co-investor |
| Lynk Pharmaceuticals | May 2023 | Series C | Co-investor |
| CytoCares (Shanghai) Inc. | May 2023 | Series A Extension | Co-investor |
| Immorna Biotherapeutics | Feb 2023 | Series A Extension | Co-investor |
| 柯润玺（南京）医药投资有限公司 | Nov 2022 | Series A | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
